Glucotrack's Lōkahi Therapeutics Announces Expansion Of ai² Platform Into Three Divisions: ai² Pipeline, ai² Talent, And ai² Accelerator; Says Platform Now Spans 13 Universities, Has Evaluated More Than 45 Therapeutic Assets
Share
Why It Matters
Glucotrack's AI platform is growing bigger and working with more universities and drug ideas. When a company expands its tools and partners, it can mean they're becoming more useful and trusted—something to watch as the company develops.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.